BNTX US09075V1026

Report

Real-time Estimate - 06/24 02:09:56 pm
233.8500	USD		+1.90%

08:13a

MARKET CHATTER : Pfizer, BioNTech COVID-19 Vaccine Found to be 90% Effective Against Delta Variant

07:41a

MARKET CHATTER : Pfizer-BioNTech Vaccine 'Very Effective' Against Delta Variant, Official Says

06:33a

EUROPEAN MIDDAY BRIEFING : Banks Lead Stocks Higher -2-

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

06/17/2021	06/18/2021	06/21/2021	06/22/2021	06/23/2021	Date
214.2(c)	212.42(c)	226.09(c)	236.49(c)	229.5(c)	Last
2 107 671	2 256 063	1 849 836	2 032 724	2 707 838	Volume
+5.08%	-0.83%	+6.44%	+4.60%	-2.96%	Change

More quotes

Estimated financial data (e)

Sales 2021	12 387 M 14 790 M 14 790 M
Net income 2021	7 065 M 8 435 M 8 435 M
Net cash position 2021	7 669 M 9 157 M 9 157 M
P/E ratio 2021	6,80x
Yield 2021	-

Sales 2022	10 740 M 12 823 M 12 823 M
Net income 2022	6 903 M 8 242 M 8 242 M
Net cash position 2022	13 186 M 15 744 M 15 744 M
P/E ratio 2022	7,58x
Yield 2022	-

Capitalization	46 467 M 55 429 M 55 479 M
EV / Sales 2021	3,13x
EV / Sales 2022	3,10x
Nbr of Employees	2 200
Free-Float	87,3%

More Financials

Company

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer...

Sector

Biotechnology & Medical Research

Calendar

08/09

Earnings Release

More about the company

Ratings of BioNTech SE

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

All news about BIONTECH SE

08:13a	MARKET CHATTER : Pfizer, BioNTech COVID-19 Vaccine Found to be 90% Effective Aga..	MT
07:41a	MARKET CHATTER : Pfizer-BioNTech Vaccine 'Very Effective' Against Delta Variant,..	MT
06:33a	EUROPEAN MIDDAY BRIEFING : Banks Lead Stocks Higher -2-	DJ
06:31a	NORTH AMERICAN MORNING BRIEFING : Stock Futures Tick Up Ahead of Jobless Claims ..	DJ
12:31a	EMEA MORNING BRIEFING : Uncertainty Over Fed -2-	DJ
06/23	ADRs End Mostly Higher; XPeng, BioNTech Among Companies Actively Trading	DJ
06/23	Nasdaq logs second straight closing high	RE
06/23	MODERNA : NIH begins clinical trial testing COVID-19 vaccine in pregnant women	RE
06/23	European ADRs Edge Higher in Wednesday Trading	MT
06/23	US' CDC To Study Possible Link Between Heart Inflammation And Pfizer/BioNTech..	MT
06/23	BIONTECH : EMA - Two additional manufacturing sites for BioNTech Pfizer's COVID..	AQ
06/23	GLOBAL MARKETS LIVE : Microsoft, Morgan Stanley, Heineken, Twitter, AstraZeneca...
06/23	SIEMENS : To Provide Technology Support For BioNTech's Vaccine Production Sites	MT
06/23	Today on Wall Street: We shall not be ruled by inflation fears
06/23	Siemens, BioNTech to Expand Vaccine Production Collaboration	DJ

More news

News in other languages on BIONTECH SE

03:37a	Merkel verteidigt Patentschutz für Corona-Impfstoffe
06/23	LONDON : Impfungen haben bereits mehr als 14 000 Leben gerettet
06/23	Siemens y BioNTech amplían colaboración para producción de vacunas
06/23	SIEMENS : collaboration industrielle renforcée avec BioNTech
06/23	Siemens und Biontech bauen Covid-19-Impfstoff-Zusammenarbeit aus

More news

Analyst Recommendations on BIONTECH SE

06/17	PFIZER : Price Target From RBC Lifted to $44 From $43 as Firm Raises Vaccine Re..	MT
06/16	BIONTECH : Redburn Downgrades BioNTech to Sell From Neutral	MT
05/19	BIONTECH : Goldman Sachs gives a Neutral rating	MD

More recommendations

Provided by Scoopnest.com

Analysis

Key EU countries rebuff Biden on sharing COVID vaccine patents